BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.71B |
| 2 |
Alibaba
BABA
|
+$2.19B |
| 3 |
Truist Financial
TFC
|
+$2.16B |
| 4 |
iShares MBS ETF
MBB
|
+$841M |
| 5 |
ServiceNow
NOW
|
+$829M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$5.15B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$2.34B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$983M |
| 4 |
VIAB
Viacom Inc. Class B
VIAB
|
+$684M |
| 5 |
Apple
AAPL
|
+$623M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Financials | 14.42% |
| 3 | Healthcare | 13.59% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Industrials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4076
Plumas Bancorp
PLBC
$429M
| $358K | ﹤0.01% |
13,572
-3,332
| -20% | -$78.7K |
|
4077
Smith & Nephew
SNN
$12.6B
| $356K | ﹤0.01% |
7,405
-11,209
| -60% | -$506K |
|
4078
Cogent Biosciences
COGT
$7.24B
| $355K | ﹤0.01% |
122,972
-36,819
| -23% | -$150K |
|
|
SVBI
4079
DELISTED
Severn Bancorp Inc/MD
SVBI
| $354K | ﹤0.01% |
38,049
+1,505
| +4% | +$12.9K |
|
|
TLGT
4080
DELISTED
Teligent, Inc
TLGT
| $352K | ﹤0.01% |
82,573
+90
| +0.1% | +$559 |
|
|
ALNA
4081
DELISTED
Allena Pharmaceuticals
ALNA
| $350K | ﹤0.01% |
128,254
-25,762
| -17% | -$84.6K |
|
4082
Astrotech Corp
ASTC
$18.1M
| $345K | ﹤0.01% |
6,389
| – | – |
|
4083
State Street SPDR Dow Jones International Real Estate ETF
RWX
$270M
| $344K | ﹤0.01% |
8,868
-6,531
| -42% | -$263K |
|
|
TULP
4084
Bloomia Holdings
TULP
$16.3M
| $342K | ﹤0.01% |
66,919
+18
| +0% | +$116 |
|
|
FSTX
4085
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $340K | ﹤0.01% |
53,779
+1,573
| +3% | +$20K |
|
|
NOVN
4086
DELISTED
Novan, Inc. Common Stock
NOVN
| $339K | ﹤0.01% |
10,706
+1,397
| +15% | +$32.8K |
|
4087
Ocugen
OCGN
$434M
| $336K | ﹤0.01% |
645,985
+645,871
| +566,554% | +$642K |
|
4088
Five Point Holdings
FPH
$375M
| $331K | ﹤0.01% |
47,683
+2,726
| +6% | +$18.6K |
|
4089
Immunic
IMUX
$195M
| $330K | ﹤0.01% |
3,400
+881
| +35% | +$73.3K |
|
4090
Traws Pharma
TRAW
$8.1M
| $329K | ﹤0.01% |
+2,290
| New | +$428K |
|
4091
Vanguard Morningstar Mega Cap Growth ETF
MGK
$34.2B
| $327K | ﹤0.01% |
11,215
+210
| +2% | +$5.8K |
|
|
HEPA
4092
DELISTED
Hepion Pharmaceuticals
HEPA
| $325K | ﹤0.01% |
+61
| New | +$236K |
|
4093
Nexa Resources
NEXA
$1.87B
| $324K | ﹤0.01% |
39,717
-2,733
| -6% | -$24.9K |
|
|
ICBK
4094
DELISTED
County Bancorp, Inc. Common Stock
ICBK
| $324K | ﹤0.01% |
12,630
-120
| -0.9% | -$2.78K |
|
|
CDOR
4095
DELISTED
Condor Hospitality Trust, Inc. Common Stock
CDOR
| $324K | ﹤0.01% |
29,406
+4,065
| +16% | +$45K |
|
|
ORGS
4096
DELISTED
Orgenesis Inc. Common Stock
ORGS
| $322K | ﹤0.01% |
6,914
+931
| +16% | +$31K |
|
|
CHRN
4097
ChronoScale Holdings
CHRN
$3.04B
| $321K | ﹤0.01% |
3,648
+11
| +0.3% | +$1.36K |
|
|
GNCA
4098
DELISTED
Genocea Biosciences, Inc.
GNCA
| $316K | ﹤0.01% |
152,526
+67,757
| +80% | +$161K |
|
4099
Virco
VIRC
$96.3M
| $313K | ﹤0.01% |
73,861
+129
| +0.2% | +$515 |
|
4100
Lesaka Technologies
LSAK
$420M
| $310K | ﹤0.01% |
83,256
+69,736
| +516% | +$231K |
|
Similar funds
BlackRock's Q4 2019 Portfolio in Review
As of Q4 2019, BlackRock held 5,193 positions worth $2.61T, up 9.5% from $2.38T the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock's Q4 2019 filing shows 167 new, 2,887 increased, 1,450 reduced and 161 closed positions. Its largest new stake was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M. The largest sale was Celgene Corp, an estimated $5.15B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- BlackRock's largest Q4 2019 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M.
- BlackRock added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.71B increase.
- BlackRock's biggest Q4 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $983M.
- BlackRock fully exited Celgene Corp in Q4 2019, selling an estimated $5.15B.
- BlackRock's ten largest holdings make up 15% of its $2.61T portfolio in Q4 2019.
- BlackRock opened 167 new positions and closed 161 in Q4 2019.
- BlackRock's portfolio value rose 9.5% quarter-over-quarter to $2.61T.
Based on BlackRock's 13F filing for Q4 2019, filed 13 Feb 2020.